
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
The American Journal of Managed Care
about 24 years ago
A Word From the New Editorsabout 24 years ago
The Costs of Medical Research: Still Not a Simple Story to Tell




